Katsumoto T - Search Results

1

PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2.

Aikawa Y, Katsumoto T, Zhang P, Shima H, Shino M, Terui K, Ito E, Ohno H, Stanley ER, Singh H, Tenen DG, Kitabayashi I. Aikawa Y, et al. Among authors: katsumoto t. Nat Med. 2010 May;16(5):580-5, 1p following 585. doi: 10.1038/nm.2122. Epub 2010 Apr 25. Nat Med. 2010. PMID: 20418886 Free PMC article.

2

MOZ is essential for maintenance of hematopoietic stem cells.

Katsumoto T, Aikawa Y, Iwama A, Ueda S, Ichikawa H, Ochiya T, Kitabayashi I. Katsumoto T, et al. Genes Dev. 2006 May 15;20(10):1321-30. doi: 10.1101/gad.1393106. Genes Dev. 2006. PMID: 16702405 Free PMC article.

3

Essential role of PU.1 in maintenance of mixed lineage leukemia-associated leukemic stem cells.

Aikawa Y, Yamagata K, Katsumoto T, Shima Y, Shino M, Stanley ER, Cleary ML, Akashi K, Tenen DG, Kitabayashi I. Aikawa Y, et al. Among authors: katsumoto t. Cancer Sci. 2015 Mar;106(3):227-36. doi: 10.1111/cas.12593. Epub 2015 Feb 12. Cancer Sci. 2015. PMID: 25529853 Free PMC article.

4

Ring1A and Ring1B inhibit expression of Glis2 to maintain murine MOZ-TIF2 AML stem cells.

Shima H, Takamatsu-Ichihara E, Shino M, Yamagata K, Katsumoto T, Aikawa Y, Fujita S, Koseki H, Kitabayashi I. Shima H, et al. Among authors: katsumoto t. Blood. 2018 Apr 19;131(16):1833-1845. doi: 10.1182/blood-2017-05-787226. Epub 2018 Jan 25. Blood. 2018. PMID: 29371181 Free article.

5

PML-retinoic acid receptor alpha inhibits PML IV enhancement of PU.1-induced C/EBPepsilon expression in myeloid differentiation.

Yoshida H, Ichikawa H, Tagata Y, Katsumoto T, Ohnishi K, Akao Y, Naoe T, Pandolfi PP, Kitabayashi I. Yoshida H, et al. Among authors: katsumoto t. Mol Cell Biol. 2007 Aug;27(16):5819-34. doi: 10.1128/MCB.02422-06. Epub 2007 Jun 11. Mol Cell Biol. 2007. PMID: 17562868 Free PMC article.

6

Roles of the histone acetyltransferase monocytic leukemia zinc finger protein in normal and malignant hematopoiesis.

Katsumoto T, Yoshida N, Kitabayashi I. Katsumoto T, et al. Cancer Sci. 2008 Aug;99(8):1523-7. doi: 10.1111/j.1349-7006.2008.00865.x. Cancer Sci. 2008. PMID: 18754862 Free article. Review.

7

MOZ is critical for the development of MOZ/MLL fusion-induced leukemia through regulation of Hoxa9/Meis1 expression.

Katsumoto T, Ogawara Y, Yamagata K, Aikawa Y, Goitsuka R, Nakamura T, Kitabayashi I. Katsumoto T, et al. Blood Adv. 2022 Oct 11;6(19):5527-5537. doi: 10.1182/bloodadvances.2020003490. Blood Adv. 2022. PMID: 35947126 Free PMC article.

8

MLL is essential for NUP98-HOXA9-induced leukemia.

Shima Y, Yumoto M, Katsumoto T, Kitabayashi I. Shima Y, et al. Among authors: katsumoto t. Leukemia. 2017 Oct;31(10):2200-2210. doi: 10.1038/leu.2017.62. Epub 2017 Feb 17. Leukemia. 2017. PMID: 28210005

9

IDH2 and NPM1 Mutations Cooperate to Activate Hoxa9/Meis1 and Hypoxia Pathways in Acute Myeloid Leukemia.

Ogawara Y, Katsumoto T, Aikawa Y, Shima Y, Kagiyama Y, Soga T, Matsunaga H, Seki T, Araki K, Kitabayashi I. Ogawara Y, et al. Among authors: katsumoto t. Cancer Res. 2015 May 15;75(10):2005-16. doi: 10.1158/0008-5472.CAN-14-2200. Epub 2015 Mar 20. Cancer Res. 2015. PMID: 25795706

10

Dual inhibition of EZH1/2 breaks the quiescence of leukemia stem cells in acute myeloid leukemia.

Fujita S, Honma D, Adachi N, Araki K, Takamatsu E, Katsumoto T, Yamagata K, Akashi K, Aoyama K, Iwama A, Kitabayashi I. Fujita S, et al. Among authors: katsumoto t. Leukemia. 2018 Apr;32(4):855-864. doi: 10.1038/leu.2017.300. Epub 2017 Sep 27. Leukemia. 2018. PMID: 28951561

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page